Psychemedics Blog Posts | News

Rebuilding A Workplace After COVID-19 (Part Three of Three)

May 24, 2020

Playing Defense. Things To Know About Detection & Deterrence. (Part Three of a Three-Part Series: “Rebuilding A Workplace After COVID-19”) “The best defense is a good offense.” Conventional wisdom, locker…

Rebuilding A Workplace After COVID-19 (Part Two of Three)

May 24, 2020

admin

Blog Posts, News

A Shifting Threat and Why 70% is a Number To Remember (Part Two of a Three-Part Series: “Rebuilding A Workplace After COVID-19”) “… other types of disasters — have led…

Rebuilding A Workplace After COVID-19 (Part One of Three)

May 24, 2020

admin

Blog Posts, News

Stress, Self-Medication, and What History Teaches Us (Part One of a Three-Part Series: “Rebuilding A Workplace After COVID-19”) “The more you know about the past, the better prepared you are…

Psychemedics Announces a “Vaping Panel” to Detect and Deter the use of Marijuana, CBD and Nicotine

May 8, 2020

admin

Blog Posts, Press Releases

A New and Cost-Effective Tool to Combat the E-cigarette Epidemic Among Youth ACTON, MA, May 5, 2020 (GLOBE NEWSWIRE) — Psychemedics Corporation (NASDAQ: PMD), the world leader and pioneer in…

Psychemedics Test for Cotinine (metabolite of Nicotine) Detection Cleared by FDA

April 29, 2020

admin

Blog Posts, Press Releases

A New and Cost-Effective Tool to Detect and Deter Nicotine use ACTON, MA, April 29, 2020 (GLOBE NEWSWIRE) — Psychemedics Corporation (NASDAQ: PMD), the world leader and pioneer in detecting…

Psychemedics Statement on COVID-19 from CEO Ray Kubacki

March 19, 2020

admin

Blog Posts, Corporate, Drug News, News

To our clients, friends, and partners: In this time of uncertainty, we are taking steps to continue delivering the superior levels of service for which Psychemedics has become known. First,…

More CBD Education Required before we call CBD a Cure-all

September 9, 2019

AllenJ@psychemedics.com

Blog Posts, Drug News

Medicinal cannabis with extract oil. Molecular structure medical chemistry formula hemp CBD – THC I read a column in my local paper serving a community north of Boston of about…

Psychemedics Test for Fentanyl Detection Cleared by FDA

April 25, 2019

Psychemedics

Blog Posts, Press Releases

Industry’s first and only FDA-cleared Fentanyl screen available now ACTON, MA, April 24, 2019 (GLOBE NEWSWIRE) — Psychemedics Corporation (NASDAQ:PMD), the world leader and pioneer in detecting drugs of abuse…

Psychemedics Announces First Quarter Results And Declares 91st Consecutive Quarterly Dividend

April 25, 2019

Psychemedics

Press Releases

Acton, MA, April 23, 2019 — Psychemedics Corporation (NASDAQ:PMD) today announced first-quarter financial results for the period ended March 31, 2019. The Company also announced a quarterly dividend of $0.18…

New Psychemedics Offering Further Enhances Cocaine Detection

March 27, 2019

admin

Press Releases

Industry’s first commercial application of hydroxycocaines for detection SAN ANTONIO, TX and ACTON, MA, March 27, 2019 (GLOBE NEWSWIRE) — Psychemedics Corporation (NASDAQ: PMD), the world leader in detecting drugs…

Rebuilding A Workplace After COVID-19 (Part Three of Three)

Rebuilding A Workplace After COVID-19 (Part Two of Three)

Rebuilding A Workplace After COVID-19 (Part One of Three)

Psychemedics Announces a “Vaping Panel” to Detect and Deter the use of Marijuana, CBD and Nicotine

Psychemedics Test for Cotinine (metabolite of Nicotine) Detection Cleared by FDA

Psychemedics Statement on COVID-19 from CEO Ray Kubacki

More CBD Education Required before we call CBD a Cure-all

Psychemedics Test for Fentanyl Detection Cleared by FDA

Psychemedics Announces First Quarter Results And Declares 91st Consecutive Quarterly Dividend

New Psychemedics Offering Further Enhances Cocaine Detection

Recent Posts

Categories

Archives